NK

Naresh Kumar

Active Director Director DIN 07643530
DIN 07643530 First appointment Oct 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2016
Shareholding value •••• Premium profile

About Naresh Kumar

Data last updated:

Naresh Kumar is a Director at Gylus Pharmaceuticals Private Limited (since 2016). The company operates in Trading. Gylus Pharmaceuticals Private Limited reported revenue of ₹66.9 Lakh (FY 2023).

DIN 07643530
Primary Designation Director
Industry Trading
First Appointment 24 Oct 2016
Oldest Company Age 10 yrs
Largest company Gylus Pharmaceuticals Private Limited · ₹66.9 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Oct 20162016₹66.9 Lakh (FY 2023)Active

Board colleagues of Naresh Kumar

NameDINCompanyDesignation
Anoop Singh Lohiya07368776Gylus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gylus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Naresh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Kumar

Naresh Kumar currently holds 1 directorship: Gylus Pharmaceuticals Private Limited (Director, since 24 Oct 2016, revenue ₹66.9 Lakh (FY 2023)).

Naresh Kumar was first appointed on 24 Oct 2016 as Director at Gylus Pharmaceuticals Private Limited.

The current boards of Naresh Kumar's companies include Anoop Singh Lohiya (Gylus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available